Radius Health (RDUS) Tops Q4 EPS by 48c, Revenues Beat; Offers FY20 Revenue Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Radius Health Announces Fourth Quarter and Full-Year 2019 Operating Results
February 27, 2020 7:30 AM ESTTYMLOS® U.S. net sales grew to $56 million in the fourth quarter of 2019,
 totaling $173M for full-year 2019, exceeding the Companys guidance of $168 to 172M
TYMLOS exited 2019 with majority share in new patients1, on track for market leadership in 2020
2020 TYMLOS U.S. net revenue expected to be between $220 and $235M and  full-year cash burn expected to be below $80M
Recruitment of three Phase 3 studies is advancing and expected to be completed in 2020, with anticipated data read-outs in... More
